Hormonal
Bariatric surgery induces high rates of type 2 diabetes remission and prevention, with effects persisting for at least 10-15 years, although some relapse occurs over time.
Bariatric surgery is highly effective at putting type 2 diabetes into remission, with most patients achieving remission within two years. While some patients may experience a return of diabetes over 10 years, the long-term risk of developing diabetes remains significantly lower than in non-surgical patients. Surgery is a powerful tool for diabetes management and prevention.
The diabetes remission rate was increased severalfold at 2 years [adjusted odds ratio (OR) = 8.42; P < 0.001] and 10 years (adjusted OR = 3.45; P < 0.001).
Why this rating
Prospective, controlled study with long-term follow-up and objective biochemical measurements.
Source
Review of the key results from the Swedish Obese Subjects (<scp>SOS</scp>) trial – a prospective controlled intervention study of bariatric surgery
L. Sjöström · Journal of Internal Medicine · 2013
DOI 10.1111/joim.12012
More from this paper
- Bariatric surgery significantly reduces overall mortality, diabetes incidence, and cardiovascular events compared to usual care in obese patients over long-term follow-up.Strong
- High baseline insulin and/or glucose levels predict favorable treatment effects from bariatric surgery, whereas high baseline BMI does not.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →